Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
Pope Says Church Should Apologize to Gays for Orlando Shooting
SHOCKER: Police Say Leftists Started Violence at Rally in Sacramento
Putin on Brexit: "Some Don't Want to Dissolve National Borders"
Bill O'Reilly on Brexit Motive: "In Parts of London, You're Not Really in England, You're in Pakistan"
Walls For Me But Not For Thee: Zuckerberg Builds Giant Wall Around Hawaii Property
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.